Stephen J. Luen

305 Grattan St
Melbourne, VIC 3000, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Biomarker testing in advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2 negative breast cancer: expert recommendations.

Biomarker testing in advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2 negative breast cancer: expert recommendations.

Journal: Therapeutic advances in medical oncology

Published: January 21, 2026

Tailoring targeted therapies for younger women with ER-positive early-stage breast cancer.

Tailoring targeted therapies for younger women with ER-positive early-stage breast cancer.

Journal: Nature reviews. Clinical oncology

Published: January 08, 2026

Systemic Therapy Management Strategies for Early-Stage Breast Cancer in Australia.

Systemic Therapy Management Strategies for Early-Stage Breast Cancer in Australia.

Journal: Asia-Pacific journal of clinical oncology

Published: December 04, 2025

Consensus guidelines for patient and carer education on neutropenic fever.

Consensus guidelines for patient and carer education on neutropenic fever.

Journal: Internal medicine journal

Published: October 16, 2025

Clinical Utility of an RNA-based Gene Fusion Assay in Sarcoma for Diagnosis and Management: Experience in an Australian Laboratory.

Clinical Utility of an RNA-based Gene Fusion Assay in Sarcoma for Diagnosis and Management: Experience in an Australian Laboratory.

Journal: Molecular diagnosis & therapy

Published: July 28, 2025

Impact of age and comorbidity on safety outcomes in phase 1 trial participants for metastatic solid malignancies.

Impact of age and comorbidity on safety outcomes in phase 1 trial participants for metastatic solid malignancies.

Journal: Journal of geriatric oncology

Published: April 07, 2025

Pathologist-initiated whole genome and transcriptome sequencing demonstrates diagnostic utility in resolving difficult-to-diagnose tumors.

Pathologist-initiated whole genome and transcriptome sequencing demonstrates diagnostic utility in resolving difficult-to-diagnose tumors.

Journal: Genome medicine

Published: March 12, 2025

Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2-Low, Hormone Receptor-Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical Trials.

Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2-Low, Hormone Receptor-Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical Trials.

Journal: JCO precision oncology

Published: January 24, 2025

Real-World Trends and Outcomes for Localized High-Grade Soft Tissue Sarcoma: Insights from a Sarcoma Unit in Australia.

Real-World Trends and Outcomes for Localized High-Grade Soft Tissue Sarcoma: Insights from a Sarcoma Unit in Australia.

Journal: Asia-Pacific journal of clinical oncology

Published: January 23, 2025

Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid Tumors.

Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid Tumors.

Journal: Cancer research communications

Published: January 02, 2025

Enhancing the quality and impact of clinical trials in soft tissue sarcoma.

Enhancing the quality and impact of clinical trials in soft tissue sarcoma.

Journal: Cancer

Published: October 25, 2024

Aboriginal and Torres Strait Islander Females and Survival from Breast Cancer.

Aboriginal and Torres Strait Islander Females and Survival from Breast Cancer.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: October 17, 2024

Showing 1-12 of 60

Last Updated: 09/26/2026